SCHEMBL9672136

SCHEMBL9672136

O=C1NC(=O)C(c2cc(F)cc(F)c2)(c2cc(F)cc(F)c2)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.53
▸ CACNA1F O60840 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ HTR2A P28223 1/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ SCN1A P35498 1/20 0.53
▸ SCN4A P35499 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ PMP22 Q01453 1/20 0.53
▸ CACNA1D Q01668 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ CACNA1S Q13698 1/20 0.53
▸ CACNA1C Q13936 1/20 0.53
▸ SCN5A Q14524 1/20 0.53
▸ SCN2A Q99250 1/20 0.53
▸ SCN3A Q9NY46 1/20 0.53
▸ AKR1B1 P15121 13/20 0.53
▸ AKR1A1 P14550 12/20 0.53
▸ ITGA4 P13612 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15955872 0.89 CYP2C9 (0.73) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL22380789 0.81 CYP2C9 (0.61) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL3660535 0.79 CYP2C9 (0.64) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL20291006 0.76 CYP2C9 (0.59) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL26232326 0.75 CYP2C9 (0.56) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL25892779 0.73 CYP2C9 (0.51) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL10929665 0.73 CYP2C9 (0.79) CYP2C9CACNA1FALDH1A1MAPTHTR2A
SCHEMBL9674175 0.73 AKR1A1 (0.60) AKR1B1AKR1A1ITGA4
SCHEMBL20290102 0.72 AKR1B1 (0.73) CYP2C9CACNA1FALDH1A1MAPTHTR2A
Phenytoin SCHEMBL3440 0.70 CYP2C9 (1.00) CYP2C9CACNA1FALDH1A1MAPTHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153211-A Enzyme inhibitors ALCON LABORATORIES, INC. (US) 1992-10-06 — — US disclosed
US-5070100-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1991-12-03 — — US disclosed
US-4864028-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1989-09-05 — — US disclosed
Send feedback